This year’s European property reinsurance renewals have so far been dominated by discussions over the treatment of Covid-19 losses, with little clarity yet on cedants’ loss figures or consensus on pricing.
This year’s European property reinsurance renewals have so far been dominated by discussions over the treatment of Covid-19 losses, with little clarity yet on cedants’ loss figures or consensus on pricing.